Search for content, post, videos

B cells in the immunotherapy spotlight

B cells
New studies focus on B cells in lymphoid structures within tumors. Three recent papers in Nature could help improve cancer treatment by immune checkpoint blockade (ICB). Checkpoint inhibitors such as the antibody therapies ipilimumab, nivolumab, and pembrolizumab promote a response against cancer
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.